{"DataElement":{"publicId":"4383252","version":"1","preferredName":"PI-RADS DCE-MRI Assessed Score","preferredDefinition":"Score to represent a structured reporting scheme for multiparametric prostate cancer imaging using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS) with a modification of contrast-enhanced MRI that allows observation of functional properties in addition to structural properties.","longName":"PIRADS_DCE_MRI_SC","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"4383079","version":"1","preferredName":"PI-RADS DCE-MRI Assessed","preferredDefinition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy._A modification of contrast-enhanced MRI that allows observation of functional properties in addition to structural properties._The final result of a determination of the value, significance, or extent of.","longName":"4382371v1.0:4383077v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"4382371","version":"1","preferredName":"Prostate Imaging-Reporting and Data System","preferredDefinition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.","longName":"C116385","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Imaging-Reporting and Data System","conceptCode":"C116385","definition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB2CAE4-93A8-073E-E040-BB89AD437130","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4383077","version":"1","preferredName":"Dynamic Contrast-enhanced Magnetic Resonance Imaging Assessment","preferredDefinition":"A modification of contrast-enhanced MRI that allows observation of functional properties in addition to structural properties.:The final result of a determination of the value, significance, or extent of.","longName":"C62665:C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dynamic Contrast-Enhanced Magnetic Resonance Imaging","conceptCode":"C62665","definition":"A modification of contrast-enhanced MRI that allows observation of functional properties in addition to structural properties.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDC84AA1-9C9A-FC5A-E040-BB89AD433AD9","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"ONEDATA","dateModified":"2014-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDC84AA1-9CAB-FC5A-E040-BB89AD433AD9","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"7/9/14 created for C3D (Dr. Pinto) PI-RADS Protocol 14C0112. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4382611","version":"1","preferredName":"PI-RADS Dynamic Contrast-enhanced Magnetic Resonance Imaging Score","preferredDefinition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy._A modification of contrast-enhanced MRI that allows observation of functional properties in addition to structural properties._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"PIRADS_DCEMRI_SCORE","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":"Type 1 enhancement curve","ValueMeaning":{"publicId":"4396031","version":"1","preferredName":"Type 1 enhancement curve","longName":"4396031","preferredDefinition":"Type 1 represents progressive enhancement","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEC81434-C692-146F-E040-BB89AD431DCD","latestVersionIndicator":"Yes","beginDate":"2014-07-22","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FEC81434-C6AB-146F-E040-BB89AD431DCD","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-22","modifiedBy":"ONEDATA","dateModified":"2014-07-22","deletedIndicator":"No"},{"value":"2","valueDescription":"Type 2 enhancement curve","ValueMeaning":{"publicId":"4396032","version":"1","preferredName":"Type 2 enhancement curve","longName":"4396032","preferredDefinition":"Type 2 rapid enhancement with plateauing.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEC81434-C6B5-146F-E040-BB89AD431DCD","latestVersionIndicator":"Yes","beginDate":"2014-07-22","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FEC81434-C6CE-146F-E040-BB89AD431DCD","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-22","modifiedBy":"ONEDATA","dateModified":"2014-07-22","deletedIndicator":"No"},{"value":"3","valueDescription":"Type 3 enhancement curve","ValueMeaning":{"publicId":"4396033","version":"1","preferredName":"Type 3 enhancement curve","longName":"4396033","preferredDefinition":"Type 3 represents rapid enhancement followed by a rapid wash out of the contrast material.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEC81434-C6D8-146F-E040-BB89AD431DCD","latestVersionIndicator":"Yes","beginDate":"2014-07-22","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FEC81434-C6F1-146F-E040-BB89AD431DCD","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-22","modifiedBy":"ONEDATA","dateModified":"2014-07-22","deletedIndicator":"No"},{"value":"4","valueDescription":"Focal enhancing lesion with curve type 2-3.","ValueMeaning":{"publicId":"4396034","version":"1","preferredName":"Focal enhancing lesion with curve type 2-3.","longName":"4396034","preferredDefinition":"Focal enhancing lesion with curve type 2-3.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEC81434-C6FB-146F-E040-BB89AD431DCD","latestVersionIndicator":"Yes","beginDate":"2014-07-22","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-22","modifiedBy":"COOPERM","dateModified":"2020-03-16","changeDescription":"Removed special characters for MDR data migration. 3.16.20 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FEC81434-C714-146F-E040-BB89AD431DCD","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-22","modifiedBy":"ONEDATA","dateModified":"2014-07-22","deletedIndicator":"No"},{"value":"5","valueDescription":"Asymmetric lesion or lesion at an unusual place with curve type 2-3","ValueMeaning":{"publicId":"4396035","version":"1","preferredName":"Asymmetric lesion or lesion at an unusual place with curve type 2-3","longName":"4396035","preferredDefinition":"Asymmetric lesion or lesion at an unusual place with curve type 2-3.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEC81434-C71E-146F-E040-BB89AD431DCD","latestVersionIndicator":"Yes","beginDate":"2014-07-22","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-22","modifiedBy":"COOPERM","dateModified":"2020-03-16","changeDescription":"Removed special characters for MDR data migration. 3.16.20 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FEC81434-C737-146F-E040-BB89AD431DCD","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-22","modifiedBy":"ONEDATA","dateModified":"2014-07-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4382610","version":"1","preferredName":"Prostate Imaging-Reporting and Data System Dynamic Contrast-enhanced Magnetic Resonance Imaging Score","preferredDefinition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.:A modification of contrast-enhanced MRI that allows observation of functional properties in addition to structural properties.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C116385:C62665:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Imaging-Reporting and Data System","conceptCode":"C116385","definition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Dynamic Contrast-Enhanced Magnetic Resonance Imaging","conceptCode":"C62665","definition":"A modification of contrast-enhanced MRI that allows observation of functional properties in addition to structural properties.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB6E260-0799-945F-E040-BB89AD432A62","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB6E260-07AA-945F-E040-BB89AD432A62","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"COOPERM","dateModified":"2020-03-16","changeDescription":"7/22/14 corrected VM/VMD per user document. jc 7/8/14 created for C3D (Dr. Pinto) PI-RADS Protocol 14C0112. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[{"name":"MRI_PIRADS_SCR","type":"DCP Alt Name","context":"DCP"}],"ReferenceDocuments":[{"name":"Dynamic Contrast Enhanced (DC","type":"Preferred Question Text","description":"Dynamic Contrast Enhanced (DCE)-MRI PI-RADS score","url":null,"context":"CCR"},{"name":"Short Text","type":"Alternate Question Text","description":"DCE-MRI PI-RADS Score","url":null,"context":"CCR"},{"name":"DCP-Text-1","type":"Alternate Question Text","description":"Highest MRI PI-RADS Score","url":null,"context":"DCP"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDCAF842-73E9-C996-E040-BB89AD43203C","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":"2015-08-04","createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"MMADDINENI","dateModified":"2024-01-15","changeDescription":"8/4/15 unretired per owner request; this CDE is needed for PI-RADSv1 questions. 8/4/2015 retired and superceded by CDE 4928130 curated for PI-RADSv2 response set./tt_Curated to support NCI intramural program CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}